Clinical Trial Update: Vitamin D and SGLT-2 Inhibitor in CPAP-naive Obstructive Sleep Apnea [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating Vitamin D and an SGLT-2 inhibitor for CPAP-naive obstructive sleep apnea has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• SGLT-2 inhibitor
• Vitamin D3 (Cholecalciferol)

Snippet

Sponsor: University Malaysia Sarawak | Conditions: Obstructive Sleep Apnea | Phase 3 | Status: COMPLETED